Gender, breast cancer, follow up
Item
women with breast cancer on well follow-up at regional cancer centres in ontario and manitoba
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C1522577 (UMLS CUI [3])
date of diagnosis
Item
diagnosed at least 12 months previously (range 9-15 months)
boolean
C2316983 (UMLS CUI [1,1])
C1274082 (UMLS CUI [1,2])
no active disease
Item
without evidence of active disease (i.e., stages iiib and iv excluded)
boolean
C2707252 (UMLS CUI [1])
treatment complications
Item
free from any primary treatment complications
boolean
C0679861 (UMLS CUI [1])
primary treatment date, tamoxifen
Item
primary treatment at least 3 months previously, except for continued use of tamoxifen
boolean
C1708063 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
complications of primary treatment
Item
still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
boolean
C0679861 (UMLS CUI [1])
C1708063 (UMLS CUI [2])
family physician to provide follow-up
Item
unable to identify an acceptable family physician to provide follow-up
boolean
C1522577 (UMLS CUI [1])
language
Item
language or literacy skills inconsistent with completing questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1145677 (UMLS CUI [1,3])
unable to comply
Item
unable to comply with study protocol including completion of questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
study participation status
Item
previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
boolean
C2348568 (UMLS CUI [1])
malignancies
Item
actively followed at a cancer centre for another primary cancer
boolean
C0006826 (UMLS CUI [1])